Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CRBP compared with NSPR: revenue, margins and what each company keeps, and the suppliers and customers both name
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Change
Mkt cap
Revenue
Revenue
NSPR
InspireMD, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CRBP
Corbus Pharmaceuticals Holdings, Inc.
vs
NSPR
InspireMD, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CRBP, solid
NSPR, dashed
Supply-chain overlap
Revenue flow
CRBP: latest quarter is a loss; flow not drawable. NSPR: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CRBP
5
—
CSPC Megalith Biopharmaceutical
unlisted
supplier
—
Jenrin Discovery
unlisted
supplier
—
Regents of the University of California
unlisted
supplier
—
K2 HealthVentures
unlisted
supplier
1 more · CRBP chain
›
Shared
0
No shared counterparties.
Only NSPR
1
—
Jacobs Institute
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Change
4.20
▼
−0.43%
· post 4.20
Mkt cap
$81.6M
Revenue
$1M
Q2 FY26
Revenue
$6M
FY25
NSPR
InspireMD, Inc.
Change
0.45
▼
−0.33%
· post 0.45
Closed
Oct 30 '26
Mkt cap
$20.9M
Revenue
$2M
Q2 FY26
Revenue
$9M
FY25
vs
Compare
Closed
Oct 30 '26
CRBP
Corbus Pharmaceuticals Holdings, Inc.
vs
NSPR
InspireMD, Inc.
4.20
▼
−0.43%
post 4.20
Price
0.45
▼
−0.33%
post 0.45
$81.6M
Mkt cap
$20.9M
Q2 FY26
$1M
Revenue
$2M
Q2 FY26
FY25
$6M
Revenue
$9M
FY25
Change
Change
CRBP
4.20
▼
−0.43%
vs
NSPR
0.45
▼
−0.33%
Closed
Oct 30 '26